A clear breakdown of every DSCSA enforcement deadline by trading partner type - manufacturers, wholesalers, large and small dispensers - and what happens when exemptions end.
DSCSA in 2026: Full Electronic Interoperability Across Digital Transformation and Daily Operations
This article focuses on DSCSA from an operational execution perspective, how interoperability behaves inside daily warehouse, quality, and supply chain workflows.
Hyperautomation Hits Pharma: Merging RPA and AI for End-to-End Supply Chain Efficiency
This blog post will explore the power of hyperautomation, its most impactful applications, and the strategic guidance needed to navigate the inevitable workforce and cultural shifts, highlighting quick wins that many competitors overlook.
Reshoring and Nearshoring: Rebuilding Pharma Supply Chains for Localization and Resilience
For decades, the global pharmaceutical industry operated on a model of maximum efficiency, often driven by the pursuit of the lowest cost. This led to a highly complex, geographically dispersed pharma supply chain, with raw material suppliers, API (Active Pharmaceutical Ingredient) manufacturers, and drug packagers often located thousands of miles...
On-Demand Pharma: Adapting Supply Chains for Personalized Medicine and Small-Batch Production
Personalized medicine, or precision medicine, is a fundamental change in how we treat disease. Instead of a single drug for a broad population, these therapies are designed for a patient's unique biological and genetic profile.
